SB-334867 free base
SB-334867 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX1, with around 50x selectivity for OX1 over OX2 receptors. It has been shown to produce sedative and anorectic effects in animals, and has been useful in characterising the orexinergic regulation of brain systems involved with appetite and sleep, as well as other physiological processes. Orexin antagonists have multiple potential clinical applications including the treatment of drug addiction, insomnia, obesity and diabetes.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD037 |
| CAS # | 792173-99-0 (free base) |
| Pricing | Customizable size, Inquiry |
| Synonym | SB-334867; SB 334867; SB334867. |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C17H13N5O2 |
| Exact Mass | 319.1069 |
| Molecular Weight | 319.324 |
| Elemental Analysis | C, 63.94; H, 4.10; N, 21.93; O, 10.02 |
| IUPAC/Chemical Name | N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl-urea |
| InChi Key | AKMNUCBQGHFICM-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23) |
| SMILES Code | O=C(NC1=CC=NC2=CC=CN=C12)NC3=CC=C4N=C(C)OC4=C3 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Class-2 | Insomnia |
| Availability | 2 Weeks |